A review of vedolizumab and ustekinumab for the treatment of inflammatory bowel diseases
Author:
Affiliation:
1. Department of Gastroenterology and Hepatology; Singapore General Hospital; Singapore
Publisher
Wiley
Subject
Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/jgh3.12065/fullpdf
Reference93 articles.
1. Surgery for adult Crohn's disease: what is the actual risk?;Bouguen;Gut,2011
2. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor a for Crohn's disease;Targan;N. Engl. J. Med.,1997
3. Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial;Khanna;Lancet,2015
4. Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease;Khanna;Aliment. Pharmacol. Ther.,2013
5. Vedolizumab as induction and maintenance therapy for Crohn's disease;Sandborn;N. Engl. J. Med.,2013
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Etanercept-synthesizing adipose-derived stem cell secretome: A promising therapeutic option for inflammatory bowel disease;World Journal of Gastrointestinal Surgery;2024-03-27
2. Biologics, Small Molecules and More in Inflammatory Bowel Disease: The Present and the Future;Future Pharmacology;2024-03-14
3. Comparison of the Effectiveness of Vedolizumab and Ustekinumab in Crohn’s Disease Patients Who Failed Anti-tumor Necrosis Factor-α Treatment in Japan: An Observational Study Utilizing Claims Database;Biological and Pharmaceutical Bulletin;2024-02-16
4. Ozanimod: A Practical Review for Nurses and Advanced Practice Providers;Nursing: Research and Reviews;2024-02
5. Safety and Efficacy of Biologic Therapies (Ustekinumab and Vedolizumab) in the Treatment of Inflammatory Bowel Disease (IBD): A Systematic Review;Cureus;2023-11-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3